NCT06742255

Brief Summary

The goal of the present study is to verify the efficacy of stellate ganglion block (SGB) in the treatment of facial pain

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
34

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 16, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 19, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

December 20, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2024

Completed
Last Updated

December 19, 2024

Status Verified

December 1, 2024

Enrollment Period

Same day

First QC Date

December 16, 2024

Last Update Submit

December 16, 2024

Conditions

Keywords

Stellate gangliomFacial palsy

Outcome Measures

Primary Outcomes (1)

  • Primary outcome: Average motor conduction latency in six muscle of the face

    6 month

Secondary Outcomes (1)

  • Improved muscle tone

    6 months

Study Arms (2)

stellate ganglion block group

Drug: Stellate Ganglion Block

medical treatment group

Interventions

Stellate ganglion block is an injection of local anesthetic at the level of the neck to target the stellate ganglion, a sympathetic ganglion to interrupt abnormal autonomically-mediated pain in patients resistant to medical treatment

stellate ganglion block group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

facial nerve palsy patients

You may qualify if:

  • facial nerve palsy patients

You may not qualify if:

  • light of a recent myocardial infarction.
  • anticoagulant use
  • glucoma
  • lateral nerve palsy
  • emphysema
  • cardiac conduction abnormalities
  • active infection, flu, cold
  • uncontrolled cough
  • Fever
  • Very high blood pressure or if you are on blood thinners.
  • allergic reaction to local anesthetics
  • Primary and secondary coagulopathy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (5)

  • Piraccini E, Munakomi S, Chang KV. Stellate Ganglion Blocks. 2023 Aug 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK507798/

    PMID: 29939575BACKGROUND
  • Wang D. Image Guidance Technologies for Interventional Pain Procedures: Ultrasound, Fluoroscopy, and CT. Curr Pain Headache Rep. 2018 Jan 26;22(1):6. doi: 10.1007/s11916-018-0660-1.

    PMID: 29374352BACKGROUND
  • Kapral S, Krafft P, Gosch M, Fleischmann D, Weinstabl C. Ultrasound imaging for stellate ganglion block: direct visualization of puncture site and local anesthetic spread. A pilot study. Reg Anesth. 1995 Jul-Aug;20(4):323-8.

    PMID: 7577781BACKGROUND
  • Abdi S, Zhou Y, Patel N, Saini B, Nelson J. A new and easy technique to block the stellate ganglion. Pain Physician. 2004 Jul;7(3):327-31.

    PMID: 16858470BACKGROUND
  • Baig S, Moon JY, Shankar H. Review of Sympathetic Blocks: Anatomy, Sonoanatomy, Evidence, and Techniques. Reg Anesth Pain Med. 2017 May/Jun;42(3):377-391. doi: 10.1097/AAP.0000000000000591.

    PMID: 28272291BACKGROUND

MeSH Terms

Conditions

Facial ParalysisAgnosia

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral Manifestations

Central Study Contacts

Remonda Zaki Abd El Naeem

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident at anesthesia, intensive care and pain management, at Assiut University

Study Record Dates

First Submitted

December 16, 2024

First Posted

December 19, 2024

Study Start

December 20, 2024

Primary Completion

December 20, 2024

Study Completion

December 20, 2024

Last Updated

December 19, 2024

Record last verified: 2024-12